UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes

Alimentary pharmacology & therapeutics, 2011-08, Vol.34 (3), p.335-343

2011

Volltextzugriff (PDF)

Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection

Journal of viral hepatitis, 2003-07, Vol.10 (4), p.294-297

2003

Volltextzugriff (PDF)

Lamivudine therapy for chronic hepatitis B: A six-month randomized dose- ranging study

Gastroenterology (New York, N.Y. 1943), 1997-10, Vol.113 (4), p.1258-1263

1997

Volltextzugriff (PDF)

Safety and efficacy of transarterial embolization of hepatocellular adenomas

British journal of surgery, 2019-09, Vol.106 (10), p.1362-1371

2019

Volltextzugriff (PDF)

Case-orientated approach to the management of hepatocellular adenoma

British journal of surgery, 2006-12, Vol.93 (12), p.1495-1502

2006

Volltextzugriff (PDF)

Systematic review of haemorrhage and rupture of hepatocellular adenomas

British journal of surgery, 2012-07, Vol.99 (7), p.911-916

2012

Volltextzugriff (PDF)

Determinants of quality of life in chronic liver patients

Alimentary pharmacology & therapeutics, 2006-06, Vol.23 (11), p.1629-1635

2006

Volltextzugriff (PDF)

The safety of pegylated interferon alpha‐2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation

Alimentary pharmacology & therapeutics, 2005-05, Vol.21 (9), p.1163-1171

2005

Volltextzugriff (PDF)

Exacerbation of chronic hepatitis B infection after delivery

Journal of viral hepatitis, 2008-01, Vol.15 (1), p.37-41

2008

Volltextzugriff (PDF)

Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase

Gut, 2003-03, Vol.52 (3), p.420-424

2003

Volltextzugriff (PDF)

Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders

Journal of hepatology, 2003-06, Vol.38 (6), p.818-826

2003

Volltextzugriff (PDF)

Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: Does it work?

Vaccine, 2009-06, Vol.27 (27), p.3530-3535

2009

Volltextzugriff (PDF)

Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias

The Journal of pathology, 2000-10, Vol.192 (2), p.207-215

2000

Volltextzugriff (PDF)

The long-term outcome of patients with polycystic liver disease treated with lanreotide

Alimentary pharmacology & therapeutics, 2012-01, Vol.35 (2), p.266-274

2012

Volltextzugriff (PDF)

Hepatitis E prevalence among HIV infected patients with elevated liver enzymes in the Netherlands

Journal of clinical virology, 2014-08, Vol.60 (4), p.408-410

2014

Volltextzugriff (PDF)

Treatment of ruptured hepatocellular adenoma

British journal of surgery, 2001-02, Vol.88 (2), p.207-209

2001

Volltextzugriff (PDF)

Hepatitis B Immunoglobulins Inhibit Dendritic Cells and T Cells and Protect Against Acute Rejection After Liver Transplantation

American journal of transplantation, 2005-10, Vol.5 (10), p.2393-2402

2005

Volltextzugriff (PDF)

Size of lesion is not a criterion for resection during management of giant liver haemangioma

British journal of surgery, 2002-10, Vol.89 (10), p.1240-1244

2002

Volltextzugriff (PDF)

Hepatocellular carcinoma in the Netherlands incidence, treatment and survival patterns

European journal of cancer (1990), 2004-07, Vol.40 (10), p.1530-1538

2004

Volltextzugriff (PDF)

Prediction of long‐term clinical outcome in a diverse chronic hepatitis B population: Role of the PAGE‐B score

Journal of viral hepatitis, 2017-11, Vol.24 (11), p.1023-1031

2017

Volltextzugriff (PDF)

Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus

Journal of viral hepatitis, 2000-11, Vol.7 (6), p.428-434

2000

Volltextzugriff (PDF)

Retrospective study on timing of resection of hepatocellular adenoma

British journal of surgery, 2017-11, Vol.104 (12), p.1695-1703

2017

Volltextzugriff (PDF)

Efficacy of influenza vaccination in adult liver transplant recipients

Journal of medical virology, 2000-05, Vol.61 (1), p.85-93

2000

Volltextzugriff (PDF)

Molecular epidemiology of acute hepatitis B in the Netherlands in 2004: nationwide survey

Journal of medical virology, 2007-07, Vol.79 (7), p.895-901

2007

Volltextzugriff (PDF)

Acute Exacerbation of Chronic Hepatitis B Virus Infection After Withdrawal of Lamivudine Therapy

Hepatology (Baltimore, Md.), 2000-09, Vol.32 (3), p.635-639

2000

Volltextzugriff (PDF)

1 – 25 von 972

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(849)
Mit Volltextzugriff
(686)

Publikationsform

Artikel
(968)
magazinearticle
(4)

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes

Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection

Lamivudine therapy for chronic hepatitis B: A six-month randomized dose- ranging study

Safety and efficacy of transarterial embolization of hepatocellular adenomas

Case-orientated approach to the management of hepatocellular adenoma

Systematic review of haemorrhage and rupture of hepatocellular adenomas

Determinants of quality of life in chronic liver patients

The safety of pegylated interferon alpha‐2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation

Exacerbation of chronic hepatitis B infection after delivery

Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase

Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders

Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: Does it work?

Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias

The long-term outcome of patients with polycystic liver disease treated with lanreotide

Hepatitis E prevalence among HIV infected patients with elevated liver enzymes in the Netherlands

Treatment of ruptured hepatocellular adenoma

Hepatitis B Immunoglobulins Inhibit Dendritic Cells and T Cells and Protect Against Acute Rejection After Liver Transplantation

Size of lesion is not a criterion for resection during management of giant liver haemangioma

Hepatocellular carcinoma in the Netherlands incidence, treatment and survival patterns

Prediction of long‐term clinical outcome in a diverse chronic hepatitis B population: Role of the PAGE‐B score

Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus

Retrospective study on timing of resection of hepatocellular adenoma

Efficacy of influenza vaccination in adult liver transplant recipients

Molecular epidemiology of acute hepatitis B in the Netherlands in 2004: nationwide survey

Acute Exacerbation of Chronic Hepatitis B Virus Infection After Withdrawal of Lamivudine Therapy

Aktive Filter

Suchergebnisse filtern